185 related articles for article (PubMed ID: 6339618)
1. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase.
Schwartz LB; Kawahara MS; Hugli TE; Vik D; Fearon DT; Austen KF
J Immunol; 1983 Apr; 130(4):1891-5. PubMed ID: 6339618
[TBL] [Abstract][Full Text] [Related]
2. Degradation of human anaphylatoxin C3a by rat peritoneal mast cells: a role for the secretory granule enzyme chymase and heparin proteoglycan.
Gervasoni JE; Conrad DH; Hugli TE; Schwartz LB; Ruddy S
J Immunol; 1986 Jan; 136(1):285-92. PubMed ID: 3510005
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of human high molecular weight kininogen by human mast cell tryptase.
Maier M; Spragg J; Schwartz LB
J Immunol; 1983 May; 130(5):2352-6. PubMed ID: 6339626
[TBL] [Abstract][Full Text] [Related]
4. The fibrinogenolytic activity of purified tryptase from human lung mast cells.
Schwartz LB; Bradford TR; Littman BH; Wintroub BU
J Immunol; 1985 Oct; 135(4):2762-7. PubMed ID: 3161948
[TBL] [Abstract][Full Text] [Related]
5. Generation of anaphylatoxins by human beta-tryptase from C3, C4, and C5.
Fukuoka Y; Xia HZ; Sanchez-Muñoz LB; Dellinger AL; Escribano L; Schwartz LB
J Immunol; 2008 May; 180(9):6307-16. PubMed ID: 18424754
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin.
Minta JO; Man D; Movat HZ
J Immunol; 1977 Jun; 118(6):2192-8. PubMed ID: 864257
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of a specific C3a receptor on guinea pig platelets.
Fukuoka Y; Hugli TE
J Immunol; 1988 May; 140(10):3496-501. PubMed ID: 3283237
[TBL] [Abstract][Full Text] [Related]
8. The C terminus of the anaphylatoxin C3a generated upon complement activation represents a neoantigenic determinant with diagnostic potential.
Burger R; Zilow G; Bader A; Friedlein A; Naser W
J Immunol; 1988 Jul; 141(2):553-8. PubMed ID: 2454995
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis and quantification of the complement C3 derived anaphylatoxin C3a with a monoclonal antibody.
Burger R; Bader A; Kirschfink M; Rother U; Schrod L; Wörner I; Zilow G
Clin Exp Immunol; 1987 Jun; 68(3):703-11. PubMed ID: 3498585
[TBL] [Abstract][Full Text] [Related]
10. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
11. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
12. Anaphylatoxin binding and degradation by rat peritoneal mast cells. Mechanisms of degranulation and control.
Fukuoka Y; Hugli TE
J Immunol; 1990 Sep; 145(6):1851-8. PubMed ID: 1697312
[TBL] [Abstract][Full Text] [Related]
13. Generation, purification and functional characterization of three C3a anaphylatoxins in rainbow trout: role in leukocyte chemotaxis and respiratory burst.
Rotllant J; Parra D; Peters R; Boshra H; Sunyer JO
Dev Comp Immunol; 2004 Jun; 28(7-8):815-28. PubMed ID: 15043949
[TBL] [Abstract][Full Text] [Related]
14. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease.
Maruo K; Akaike T; Ono T; Okamoto T; Maeda H
J Allergy Clin Immunol; 1997 Aug; 100(2):253-60. PubMed ID: 9275149
[TBL] [Abstract][Full Text] [Related]
15. Complement activation and generation of C3a anaphylatoxin by radiological contrast agents.
Dawson P; Turner MW; Bradshaw A; Westaby S
Br J Radiol; 1983 Jul; 56(667):447-8. PubMed ID: 6602640
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary injury induced by C3a and C5a anaphylatoxins.
Stimler NP; Hugli TE; Bloor CM
Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
[TBL] [Abstract][Full Text] [Related]
17. Generation of anaphylatoxin activity related to C3a, by treatment of human serum with the nitrogen nucleophile N2H4 or the chaotrope KSCN.
von Zabern I; Damerau B; Nolte R; Grünefeld E; Vogt W
Scand J Immunol; 1985 Dec; 22(6):639-51. PubMed ID: 3937227
[TBL] [Abstract][Full Text] [Related]
18. The anaphylatoxic peptide C3a of guinea pig complement. I. Purification, physicochemical and antigenetic properties.
Meuer S; Becker S; Hadding U; Bitter-Suermann D
Z Immunitatsforsch Immunobiol; 1978 Mar; 154(2):135-46. PubMed ID: 77089
[TBL] [Abstract][Full Text] [Related]
19. The extracellular neutral cysteine proteinase of Entamoeba histolytica degrades anaphylatoxins C3a and C5a.
Reed SL; Ember JA; Herdman DS; DiScipio RG; Hugli TE; Gigli I
J Immunol; 1995 Jul; 155(1):266-74. PubMed ID: 7602103
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of human lung tryptase: evidence for a re-activatable tetrameric intermediate and active monomers.
Addington AK; Johnson DA
Biochemistry; 1996 Oct; 35(42):13511-8. PubMed ID: 8885830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
